Updates on T helper type 17 immunity in respiratory disease

Immunology

Volumn 156, Issue 1, 2019, Pages 3-8

  Iwanaga, Naoki ^a   Kolls, Jay K ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

lung; mucosal immunity; T helper type 17; tissue resident memory cells

Indexed keywords

INTERLEUKIN 17; LYMPHOCYTE ANTIGEN RECEPTOR;

ASTHMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNIZATION; LYMPHOID CELL; MEMORY CELL; MUCOSAL IMMUNITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; TH17 CELL; ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LUNG; LUNG DISEASE; METABOLISM; RESPIRATORY MUCOSA;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; LUNG; LUNG DISEASES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RESPIRATORY MUCOSA; TH17 CELLS;

EID: 85055522380     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.13006     Document Type: Review

References (77)

1. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467–76
2. Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 2007; 179:5462–73
3. + γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007; 178:4466–72
4. Mjosberg J, Spits H. Human innate lymphoid cells. J Allergy Clin Immunol 2016; 138:1265–76
5. Chen K, McAleer JP, Lin Y, Paterson DL, Zheng M, Alcorn JF et al. Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 2011; 35:997–1009
6. Malley R, Anderson PW. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc Natl Acad Sci USA 2012; 109:3623–7
7. + T cells that confer immunity to fungal ascomycetes via conserved epitopes. Cell Host Microbe 2015; 17:452–65
8. Wuthrich M, Gern B, Hung CY, Ersland K, Rocco N, Pick-Jacobs J et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 2011; 121:554–68
9. Gopal R, Monin L, Slight S, Uche U, Blanchard E, Fallert Junecko BA et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog 2014; 10:e1004099
10. Conti HR, Bruno VM, Childs EE, Daugherty S, Hunter JP, Mengesha BG et al. IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis. Cell Host Microbe 2016; 20:606–17
11. Li J, Casanova JL, Puel A. Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. Mucosal Immunol 2018; 11:581–9
12. Elsegeiny W, Zheng M, Eddens T, Gallo RL, Dai G, Trevejo-Nunez G et al. Murine models of Pneumocystis infection recapitulate human primary immune disorders. JCI Insight 2018; 3:e91894
13. H17 lineage. Nature 2006; 441:231–4
14. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003; 170:4432–6
15. Romagnoli PA, Sheridan BS, Pham Q-M, Lefrancois L, Khanna KM. IL-17A-producing resident memory γδ T cells orchestrate the innate immune response to secondary oral Listeria monocytogenes infection. Proc Natl Acad Sci USA 2016; 113:8502–7
16. Guo XJ, Dash P, Crawford JC, Allen EK, Zamora AE, Boyd DF et al. Lung γδ T cells mediate protective responses during neonatal influenza infection that are associated with type 2 immunity. Immunity 2018; 49:1–14
17. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 2009; 183:5301–10
18. Turchinovich G, Haybay AC. Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells. Immunity 2011; 35:59–68
19. Ribot JC, deBarros A, Pang DJ, Neves JF, Peperzak V, Roberts SJ et al. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17-producing γδ T cell subsets. Nat Immunol 2009; 10:427–36
20. Chien Y-H, Zeng X, Prinz I. The natural and the inducible: interleukin (IL)-17-producing γδ T cells. Trends Immunol 2013; 34:151–4
21. Gladiator A, Wangler N, Trautwein-Weidner K, Leibundgut-Landmann S. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 2013; 204:995–1001
22. Gaffen SL, Jain R, Garg A, Cua DJ. IL23-IL17 immune axis: discovery, mechanistic understanding, and clinical testing. Nat Rev Immunol 2014; 14:585–600
23. neg iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 105:19845–50
24. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206:299–311
25. Levy R, Okada S, Beziat V, Moriya K, Liu C, Chai LY et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci USA 2016; 113:E8277–85
26. Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M et al. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 2015; 349:606–13
27. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282:9358–63
28. H17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773–6
29. Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep 2008; 8:386–91
30. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124:1289–302. e4
31. Kida H, Mucenski ML, Thitoff AR, Le Cras TD, Park KS, Ikegami M et al. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am J Pathol 2008; 172:1542–54
32. Forbes LR, Milner J, Haddad E. Signal transducer and activator of transcription 3: a year in review. Curr Opin Hematol 2016; 23:23–7
33. Choi SM, McAleer JP, Zheng M, Pociask DA, Kaplan MH, Qin S et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med 2013; 210:551–61
34. + memory cells in lung draining lymph nodes. J Allergy Clin Immunol 2013; 131:1117–29
35. Tan HL, Regamey N, Brown S, Bush A, Lloyd CM, Davies JC. The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med 2011; 184:252–8
36. Dubin PJ, Martz A, Eisenstatt JR, Fox MD, Logar A, Kolls JK. Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection. Infect Immun 2012; 80:398–409
37. Dubin PJ, Kolls JK. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007; 292:L519–28
38. Hsu D, Taylor P, Fletcher D, van Heeckeren R, Eastman J, van Heeckeren A et al. Interleukin-17 pathophysiology and therapeutic intervention in cystic fibrosis lung infection and inflammation. Infect Immun 2016; 84:2410–21
39. Bayes HK, Ritchie ND, Evans TJ. Interleukin-17 is required for control of chronic lung infection caused by Pseudomonas aeruginosa. Infect Immun 2016; 84:3507–16
40. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010; 2:29ra31
41. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 2008; 321:1837–41
42. Sun X, Sui H, Fisher JT, Yan Z, Liu X, Cho HJ et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 2010; 120:3149–60
43. Mulcahy EM, Hudson JB, Beggs SA, Reid DW, Roddam LF, Cooley MA. High peripheral blood Th17 percent associated with poor lung function in cystic fibrosis. PLoS ONE 2015; 10:e0120912
44. Chen K, Eddens T, Trevejo-Nunez G, Way EE, Elsegeiny W, Ricks DM et al. IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae. Cell Host Microbe 2016; 20:596–605
45. Kreindler JL, Bertrand CA, Lee RJ, Karasic T, Aujla S, Pilewski JM et al. Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009; 296:L257–66
46. Shah VS, Meyerholz DK, Tang XX, Reznikov L, Abou Alaiwa M, Ernst SE et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science 2016; 351:503–7
47. Pezzulo AA, Tang XX, Hoegger MJ, Abou Alaiwa MH, Ramachandran S, Moninger TO et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012; 487:109–13
48. Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D et al. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Respir Crit Care Med 1999; 159:1464–8
49. O'Neal WK, Gallins P, Pace RG, Dang H, Wolf WE, Jones LC et al. Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes. Am J Hum Genet 2015; 96:318–28
50. Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG, Stonebraker JR et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 2015; 6:8382
51. Chen K, Pociask DA, McAleer JP, Chan YR, Alcorn JF, Kreindler JL et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS ONE 2011; 6:e20333
52. + T cells toward Th17 cells by CD40-CD40L costimulatory pathway in mice. Int J Chron Obstruct Pulmon Dis 2018; 13:959–68
53. H17 inflammation in human and experimental emphysema. Sci Transl Med 2012; 4:117ra9
54. Le Rouzic O, Pichavant M, Frealle E, Guillon A, Si-Tahar M, Gosset P. Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations. Eur Respir J 2017; 50:1602434
55. Shukla SD, Budden KF, Neal R, Hansbro PM. Microbiome effects on immunity, health and disease in the lung. Clin Transl Immunology 2017; 6:e133
56. Shan M, Cheng HF, Song LZ, Roberts L, Green L, Hacken-Bitar J et al. Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci Transl Med 2009; 1:4ra10
57. Rangel-Moreno J, Carragher DM, Garcia-Hernandez lL, Hwang JY, Kusser K, Hartson L et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011; 12:639–46
58. Eddens T, Elsegeiny W, Garcia-Hernadez ML, Castillo P, Trevejo-Nunez G, Serody K et al. Pneumocystis-driven inducible bronchus-associated lymphoid tissue formation requires Th2 and Th17 immunity. Cell Rep 2017; 18:3078–90
59. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 2009; 4:435–59
60. Steiling K, van den Berge M, Hijazi K, Florido R, Campbell J, Liu G et al. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med 2013; 187:933–42
61. Faner R, Cruz T, Casserras T, Lopez-Giraldo A, Noell G, Coca I et al. Network analysis of lung transcriptomics reveals a distinct B-cell signature in emphysema. Am J Respir Crit Care Med 2016; 193:1242–53
62. Roos AB, Sethi S, Nikota J, Wrona CT, Dorrington MG, Sanden C et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192:428–37
63. Mebratu YA, Tesfaigzi Y. IL-17 plays a role in respiratory syncytial virus-induced lung inflammation and emphysema in elastase and LPS-injured mice. Am J Respir Cell Mol Biol 2018; 58:717–26
64. van de Kerkhof PC, Griffiths CE, Reich K, Leonardi CL, Blauvelt A, Tsai TF et al. Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol 2016; 75:83–98. e4
65. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 2012; 26:533–45
66. Kumar P, Monin L, Castillo P, Elsegeiny W, Horne W, Eddens T et al. Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity 2016; 44:659–71
67. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135
68. Lindén A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol 2001; 126:179–84
69. Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 2015; 7:301ra129
70. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180:388–95
71. Raundhal M, Morse C, Khare A, Oriss TB, Milosevic J, Trudeau J et al. High IFN-γ and low SLPI mark severe asthma in mice and humans. J Clin Invest 2015; 125:3037–50
72. Ray A, Raundhal M, Oriss TB, Ray P, Wenzel SE. Current concepts of severe asthma. J Clin Invest 2016; 126:2394–403
73. Yang Y, Torchinsky MB, Gobert M, Xiong H, Xu M, Linehan JL et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 2014; 510:152–6
74. Kumar BV, Ma W, Miron M, Granot T, Guyer RS, Carpenter DJ et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep 2017; 20:2921–34
75. Smith NM, Wasserman GA, Coleman FT, Hilliard KL, Yamamoto K, Lipsitz E et al. Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. Mucosal Immunol 2018; 11:220–35
76. Li W, Zhang X, Yang Y, Yin Q, Wang Y, Li Y et al. Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection. Proc Natl Acad Sci USA 2018; 115:E7149–57
77. Alexis NE, Lay JC, Almond M, Bromberg PA, Patel DD, Peden DB. Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo. J Allergy Clin Immunol 2005; 115:345–50